Biomerica Posts $1.64 Mln In Q2 Revenue, Marks 5% Year-over-Year Growth

(RTTNews) - Biomerica, Inc. (BMRA) Wednesday, reported financial results for the second quarter of fiscal 2025, which ended on November 30, 2024. The company showed impressive growth and efficiency improvements across key financial metrics, demonstrating its commitment to both business expansion and operational optimization.

The company posted net sales of $1.64 million, marking a 5 percent increase from the $1.57 million reported during the same quarter last year. This growth highlights the strong demand for Biomerica's diverse product offerings, supported by both new and returning customers.

In addition to revenue growth, the operating loss decreased by 39 percent, from $1.6 million to $990,000, while the net loss dropped by 37 percent, from $1.5 million to $950,000. These improvements reflect the company's successful cost management strategies and operational streamlining efforts.

BMRA closed Wednesday's trading at $0.34 up 5.61 percent or $0.018 on the Nasdaq.